Prostate Cancer - Results from #1880

Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial. October 27, 2023

The long tail of oncogenic drivers in prostate cancer. October 27, 2023

Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer. October 27, 2023

Reliable Prostate Cancer Risk Mapping from MRI Using Targeted and Systematic Core Needle Biopsy Histopathology. October 26, 2023

Androgen deprivation therapy and cardiovascular morbidity in prostate cancer: a narrative review. October 26, 2023

Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points from a Focused Review. October 26, 2023

Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials. October 26, 2023

Overall Survival and Associations of Insurance Status Among Hispanic Men With High-Risk Prostate Cancer. October 26, 2023

Characteristics of incidental prostate cancer in the United States. October 25, 2023

Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. October 25, 2023

Location and Types of Treatment for Prostate Cancer After the Veterans Choice Program Implementation. October 25, 2023

Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. October 25, 2023

Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. October 25, 2023

Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial. October 25, 2023

Real-life Perioperative Outcomes of Radical Prostatectomy using the French National Registry: A Plea for Promotion of Centralized Care and Access to Minimally Invasive Approaches. October 24, 2023

Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI- October 24, 2023

Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial. October 24, 2023

Mental health outcomes in a population-based cohort of patients with prostate cancer. October 24, 2023

Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort. October 24, 2023

Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancer. October 24, 2023

Page 95 of 1435